Amgen CEO has shares withheld for taxes

Amgen Inc. Chairman, CEO and President Robert A. Bradway reported a routine tax-withholding transaction in company stock.

Rhea-AI Filing Summary

Amgen Inc. Chairman, CEO and President Robert A. Bradway reported a routine tax-withholding transaction in company stock. On 2026-05-07, 2,079 shares of Amgen common stock were withheld at $331.11 per share to satisfy tax obligations, not as an open-market sale.

Following this withholding, Bradway directly owns 505,160 shares of Amgen common stock. He also reports indirect holdings through related parties, including shares held by his spouse and in spousal GRAT and GRAT vehicles, reflecting additional indirect economic exposure to Amgen stock.

Insider Trade Summary

Exercise Price or Tax Liability: 2,079 shares

Exercise Price or Tax Liability 4 txns

Insider Bradway Robert A

Role Chairman, CEO and President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,079	$331.11	$688K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 505,160 shares (Direct); Common Stock — 60,060 shares (Indirect, By GRAT); Common Stock — 60,060 shares (Indirect, By Spousal GRAT); Common Stock — 29,940 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

Tax-withholding shares: 2,079 shares Tax-withholding price: $331.11 per share Direct holdings after transaction: 505,160 shares +3 more

6 metrics

Tax-withholding shares 2,079 shares Code F tax-withholding disposition on 2026-05-07

Tax-withholding price $331.11 per share Value applied to 2,079 withheld shares

Direct holdings after transaction 505,160 shares Common stock held directly after 2026-05-07

Indirect holdings by spouse 29,940 shares Common stock held indirectly by spouse

Indirect holdings by spousal GRAT 60,060 shares Common stock held indirectly by spousal GRAT

Indirect holdings by GRAT 60,060 shares Common stock held indirectly by GRAT

Key Terms

tax-withholding disposition, Dividend Equivalents (DEs), Restricted Stock Units, GRAT

4 terms

tax-withholding disposition financial

"Payment of exercise price or tax liability by delivering securities"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Dividend Equivalents (DEs) financial

"These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

GRAT financial

"nature_of_ownership": "By Spousal GRAT""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amgen (AMGN) CEO Robert Bradway report?

Robert A. Bradway reported a tax-withholding disposition of 2,079 Amgen common shares at $331.11 per share. These shares were withheld to cover tax obligations, rather than sold in the open market, and are reported as a Form 4 transaction.

How many Amgen (AMGN) shares does the CEO hold after this Form 4?

After the reported tax-withholding, Robert A. Bradway directly holds 505,160 shares of Amgen common stock. The filing also lists additional indirect holdings through his spouse and related GRAT entities, which represent further economic exposure beyond his direct ownership position.

Was the Amgen (AMGN) CEO’s Form 4 transaction a market sale?

No. The Form 4 identifies the transaction with code F, a tax-withholding disposition. This means 2,079 shares were delivered to cover exercise price or tax liabilities, rather than being sold on the open market, and is considered a routine administrative transaction.

What price per share was used in the Amgen (AMGN) CEO tax withholding?

The tax-withholding disposition used a price of $331.11 per Amgen common share for the 2,079 shares. This price is applied for the purpose of calculating the value of shares delivered to satisfy tax obligations associated with the underlying equity compensation.

What indirect Amgen (AMGN) shareholdings are reported for the CEO?

The filing lists indirect holdings in Amgen common stock by the CEO’s spouse and by spousal GRAT and GRAT entities. Reported post-transaction positions include 29,940 shares by spouse, 60,060 shares by spousal GRAT, and 60,060 shares by GRAT, in addition to his direct holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 07:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bradway Robert A

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320-1799

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		F		2,079	D	$331.11	505,160(1)	D
Common Stock								60,060	I	By GRAT
Common Stock								60,060	I	By Spousal GRAT
Common Stock								29,940	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Robert A. Bradway	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)